XML 56 R45.htm IDEA: XBRL DOCUMENT v3.19.1
Long-Term Investments (Details 4) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Net sales $ 212,242
Gross Profit 210,743
Net loss (873,317) (713,622)
Share of losses from investments accounted for using the equity method (66,205) (38,567)
Rgene Corporation [Member]    
Net sales
Gross Profit
Net loss (22,662) (36,041)
Share of losses from investments accounted for using the equity method
BioFirst Corporation [Member]    
Net sales 10,334 10,022
Gross Profit 1,882 2,372
Net loss (307,034) (178,294)
Share of losses from investments accounted for using the equity method $ (66,205) $ (38,567)